A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.
Colon cancer is one of the most common cancers in the U.S., with more than 100,000 cases diagnosed each year. But some people ...
Ferring Pharmaceuticals announces that nadofaragene firadenovec-vncg (ADSTILADRIN ®) has been upgraded to a National Comprehensive Cancer Network® (NCCN®) Category 2A recommended option for the ...
Hickey, now aged 55, underwent a third mammogram, an ultrasound and a biopsy and was shocked to be diagnosed with ductal carcinoma in situ, an early form of breast cancer.
Cases of colorectal cancer in young people have risen nearly 60 percent since the early 2000s. That’s according to data from ...
While her surgical oncologist only required the removal of the affected tissue, McFadden-Sabari made a definitive choice for her long-term peace of mind. She opted for a bilateral mastectomy without ...
NCCN now recognizes BCG-unresponsive papillary-only NMIBC as eligible for nogapendekin plus BCG, broadening access beyond the ...
Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...
Cancer the Crab is a dim constellation, yet it contains one of the most beautiful and easy-to-spot star clusters in our sky: ...
Among women using medically assisted reproduction (MAR), the overall incidence of cancer was comparable to that of the ...
Collaboration deploys the High Throughput In Situ Multiomics capabilities of G4X(TM) to support HTAN's Pre-Gastric Cancer program and enable scalable generation of multimodal 3D atlases. SAN DIEGO and ...
Researchers studied incidence rates and temporal trends for cutaneous squamous cell carcinoma, cutaneous squamous cell carcinoma in situ, and keratoacanthoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results